Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 225 publications
HER2-targeted agents and interstitial lung disease: A real-world pharmacovigilance analysis using FAERS data.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: July 07, 2025
Advancing treatment in HER2-positive metastatic breast cancer: the role of tucatinib.
Journal: Future oncology (London, England)
Published: July 07, 2025
The current status of quinazoline hybrids with antibreast cancer therapeutic potential-part II.
Journal: Future medicinal chemistry
Published: June 07, 2025
Real-world efficacy and safety of trastuzumab deruxtecan versus trastuzumab emtansine and tucatinib as second-line and third-line treatments for HER2-positive metastatic breast cancer: two target trial emulation studies.
Journal: The Lancet regional health. Europe
Published: April 29, 2025
Sequential Therapy With HER2 Tyrosine Kinase Inhibitors in Patients With HER2-Positive Metastatic Breast Cancer.
Journal: Clinical breast cancer
Published: April 28, 2025
Real-World Clinical Outcomes in Patients With HER2+ Metastatic Breast Cancer Receiving Tucatinib-Based Therapy After 2 or More Prior Metastatic HER2-Directed Regimens.
Journal: Cancer control : journal of the Moffitt Cancer Center
Published: April 19, 2025
Safety and Efficacy of Anti-Human Epidermal Growth Factor 2 Agents in the Treatment of Biliary Tract Cancers: A Systematic Review.
Journal: JCO precision oncology
Published: April 16, 2025
Isoetin from Isoetaceae Exhibits Superior Pentatransferase Inhibition in Breast Cancer: Comparative Computational Profiling with FDA-Approved Tucatinib.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: April 09, 2025
Last Updated: 10/31/2025